Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar;14(2):130-143.
doi: 10.1016/j.ajps.2018.04.004. Epub 2018 May 10.

Electrospun nanofibers as a wound dressing for treating diabetic foot ulcer

Affiliations
Review

Electrospun nanofibers as a wound dressing for treating diabetic foot ulcer

Yan Liu et al. Asian J Pharm Sci. 2019 Mar.

Abstract

Diabetes is one of the most prevalent diseases in the world with high-mortality and complex complications including diabetic foot ulcer (DFU). It has been reported that the difficulties in repairing the wound related to DFU has much relationship with the wound infection, change of inflammatory responses, lack of extracellular matrix (ECM), and the failure of angiogenesis. Following the development of medical materials and pharmaceutical technology, nanofibers has been developed by electrospinning with huge porosity, excellent humidity absorption, a better oxygen exchange rate, and some antibacterial activities. That is to say, as a potential material, nanofibers must be a wonderful candidate for the DFU treatment with so many benefits. Careful selection of polymers from natural resource and synthetic resource can widen the nanofibrous application. Popular methods applied for the nanofibrous fabrication consist of uniaxial electrospinning and coaxial electrospinning. Furthermore, nanofibers loading chemical, biochemical active pharmaceutical ingredient (API) or even stem cells can be wonderful dosage forms for the treatment of DFU. This review summarizes the present techniques applied in the fabrication of nanofibrous dressing (ND) that utilizes a variety of materials and active agents to offer a better health care for the patients suffering from DFU.

Keywords: Coaxial electrospinning; Diabetic foot ulcer; Nanofibers; Nanofibrous dressing; Uniaxial electrospinning.

PubMed Disclaimer

Figures

Image, graphical abstract
Graphical abstract
Fig 1
Fig. 1
(A) PLA fibers electrospun by portable electrospinning device on hand; (B) the final appearance of a homogenous ND; (C) removing the ND with a tweezer from skin (Reproduced with permission from .). Copyright 2015, The Royal Society of Chemistry.
Fig 2
Fig. 2
(A) Schematic apparatus used for the uniaxial electrospinning and (B) the coaxial electrospinning.
Fig 3
Fig. 3
Field-emission electron micrographs of uniaxial nanofibers made by PCL-gelatin at (A) 50 μm and (B) 20 μm. Reproduced with permission from . Copyright 2007, Elsevier.
Fig 4
Fig. 4
TEM images of coaxial nanofibers made by PEO and chitosan. (A) Concentric and (B) eccentric core and shell structures (Reproduced with permission from .). Copyright 2012, American Chemical Society.
Fig 5
Fig. 5
Photographs of the wound closure of diabetic rats on days 0, 3, 7, 14, (A) collagen/PLGA with glucophage-loaded group, (B) pure collagen/PLGA group, (C) gauze sponge group (Reproduced with permission from .). Copyright 2015, Elsevier.

References

    1. Whiting DR, Guariguata L, Weil C, Shaw J. Idf diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–321. - PubMed
    1. Majd SA, Khorasgani MR, Moshtaghian SJ, Talebi A, Khezri M. Application of chitosan/pva nano fiber as a potential wound dressing for streptozotocin-induced diabetic rats. Int J Biol Macromol. 2016;92:1162–1168. - PubMed
    1. Veves A, Falanga V, Armstrong DG, Sabolinski ML, . The Apligraf Diabetic Foot Ulcer Study Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001;24(2):290–295. - PubMed
    1. Prompers L, Schaper N, Apelqvist J. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. Eurodiale Study Diabetol. 2008;51(5):747–755. - PMC - PubMed
    1. Marston WA, Hanft J, Norwood P, Pollak R, Dermagraft Diabetic Foot Ulcer Study Group The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers – results of a prospective randomized trial. Diabetes Care. 2003;26(6):1701–1705. - PubMed

LinkOut - more resources